What this study is
The purpose of this study is to examine the impact of the nudge implementation strategy (CDS tool + Nudge) on adoption of guideline-concordant CT ordering for pulmonary embolism (PE) in 10 EDs. The study will be a 33-month, rigorous, pragmatic, cluster-randomized, stepped wedge trial across 3 health systems and 10 EDs after collecting pre-implementation baseline data. The aim is to to demonstrate technological feasibility as well as examine efficacy of the nudges on adoption. The secondary objective is to decrease CT-ordering when it is not indicated.
What's being tested
- Clinical Decision Support (CDS) tool with Nudges
Intervention · BEHAVIORAL
The CDS tool with nudges provide information to providers to practice medicine in accordance with CT (computed tomography) ordering guidelines. The tool will only deploy when the provider is going against clinical guidelines and therefore provides a chance for the provider to reconsider their actions.
Study details
- Sponsor
- NYU Langone Health
- Conditions
- Pulmonary Embolism
- Enrolling
- 440 people
- Starts
- 2026-02-15
- Est. completion
- 2029-03-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- 18 years of older
- A provider (MD, NP, PA) ordering CTs for evaluation of PE in adult patients present at study site Emergency Department (i.e., Northwell Health - Feinstein Institute for Medical Research, Baylor College of Medicine and NYU Langone Health).
You can't join if
- A provider not present at the specified study sites.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openNorthwell Health - Feinstein Institute for Medical Research
Manhasset, New York, United States
NYU Langone Health
New York, New York, United States
Baylor College of Medicine
Houston, Texas, United States
Study team
Sponsor
NYU Langone Health
Study ID 23-01528
Principal investigator
Safiya Richardson, MD MPH
NYU Langone Health
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.